- Home
- Publications
- Publication Search
- Publication Details
Title
AKT/GSK3β Signaling in Glioblastoma
Authors
Keywords
-
Journal
NEUROCHEMICAL RESEARCH
Volume 42, Issue 3, Pages 918-924
Publisher
Springer Nature
Online
2016-08-27
DOI
10.1007/s11064-016-2044-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Locking PDK1 in DFG-out conformation through 2-oxo-indole containing molecules: Another tools to fight glioblastoma
- (2016) Simona Sestito et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Role of mTOR in glioblastoma
- (2016) Zekeriya Duzgun et al. GENE
- miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway
- (2016) Hang Song et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells
- (2015) Xue-tao Li et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme
- (2015) Simona Sestito et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
- (2015) Yazmin Odia et al. JOURNAL OF NEURO-ONCOLOGY
- The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
- (2015) Hongxiang Wang et al. NEOPLASIA
- Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
- (2015) Meena Jhanwar-Uniyal et al. Cancers
- Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling
- (2014) Demirkan B. Gürsel et al. JOURNAL OF NEURO-ONCOLOGY
- Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
- (2014) M Signore et al. Cell Death & Disease
- The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas
- (2013) Zhe Bao Wu et al. BRAIN RESEARCH
- The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
- (2013) K. E. Sheppard et al. CLINICAL CANCER RESEARCH
- The evolving landscape of glioblastoma stem cells
- (2013) Kenneth Yan et al. CURRENT OPINION IN NEUROLOGY
- The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways
- (2013) Andressa Bernardi et al. International Journal of Nanomedicine
- The short chain cell-permeable ceramide (C6) restores cell apoptosis and perifosine sensitivity in cultured glioblastoma cells
- (2013) Li-sen Qin et al. MOLECULAR BIOLOGY REPORTS
- Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines
- (2013) Simona Baronchelli et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses
- (2013) Carol Dangelmaier et al. THROMBOSIS AND HAEMOSTASIS
- GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by wogonin
- (2013) Yajing Wang et al. TOXICOLOGY LETTERS
- Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas
- (2012) Ryan J. Atkins et al. JOURNAL OF CLINICAL NEUROSCIENCE
- A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)
- (2012) R. Rampling et al. NEURO-ONCOLOGY
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
- (2012) N. J. Szerlip et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice
- (2012) Guido Henke et al. Radiation Oncology
- A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
- (2011) Teri N. Kreisl et al. NEURO-ONCOLOGY
- Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
- (2011) N. Butowski et al. NEURO-ONCOLOGY
- Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
- (2011) Kenneth L. Pitter et al. PLoS One
- Striking the target in Wnt-y conditions: Intervening in Wnt signaling during cancer progression
- (2010) Tura C. Camilli et al. BIOCHEMICAL PHARMACOLOGY
- PTEN Signaling pathways in glioblastoma
- (2010) Dimpy Koul CANCER BIOLOGY & THERAPY
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
- (2010) Ce Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Higher pAkt Expression Predicts a Significant Worse Prognosis in Glioblastomas
- (2010) Yoshiyuki SUZUKI et al. JOURNAL OF RADIATION RESEARCH
- Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
- (2010) N. Butowski et al. NEURO-ONCOLOGY
- Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8
- (2010) Diana Aguilar-Morante et al. PLoS One
- Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains
- (2010) B. Miao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential Therapeutic Effect of Glycogen Synthase Kinase 3 Inhibition against Human Glioblastoma
- (2009) K. Miyashita et al. CLINICAL CANCER RESEARCH
- A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
- (2009) T. N. Kreisl et al. CLINICAL CANCER RESEARCH
- Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
- (2009) Gangadhara Reddy Sareddy et al. NEUROCHEMISTRY INTERNATIONAL
- GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
- (2009) Serdar Korur et al. PLoS One
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor- B, and Glucose Regulation
- (2008) S. Kotliarova et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started